Your browser doesn't support javascript.
loading
Dietary nitrate reduces blood pressure and cerebral artery velocity fluctuations and improves cerebral autoregulation in transient ischemic attack patients.
Fan, Jui-Lin; O'Donnell, Terrence; Lanford, Jeremy; Croft, Kevin; Watson, Eloise; Smyth, Duncan; Koch, Henrietta; Wong, Lai-Kin; Tzeng, Yu-Chieh.
Afiliação
  • Fan JL; Wellington Medical Technology Group, Department of Surgery and Anaesthesia, University of Otago, Wellington, New Zealand.
  • O'Donnell T; Centre for Translational Physiology, University of Otago, Wellington, New Zealand.
  • Lanford J; Wellington Medical Technology Group, Department of Surgery and Anaesthesia, University of Otago, Wellington, New Zealand.
  • Croft K; Centre for Translational Physiology, University of Otago, Wellington, New Zealand.
  • Watson E; Department of Neurology, Wellington Regional Hospital, Wellington, New Zealand.
  • Smyth D; School of Biomedical Science, University of Western Australia, Perth, Australia.
  • Koch H; Department of Neurology, Wellington Regional Hospital, Wellington, New Zealand.
  • Wong LK; Department of Neurology, Wellington Regional Hospital, Wellington, New Zealand.
  • Tzeng YC; School of Biomedical Science, University of Western Australia, Perth, Australia.
J Appl Physiol (1985) ; 129(3): 547-557, 2020 09 01.
Article em En | MEDLINE | ID: mdl-32758038
ABSTRACT
Accentuated blood pressure (BP) fluctuation and low cerebral blood flow (CBF) response to CO2 increase the risk of transient ischemic attack (TIA) recurrence and stroke in TIA patients. Improving cardio- and cerebrovascular function may reduce stroke risk. We found dietary nitrate lowered dynamic blood pressure variability (BPV) in rats and improved cerebrovascular CO2 reactivity in healthy individuals. In 30 TIA patients, we examined the effects of a 7-day supplementation of dietary nitrate (0.1 mmol·kg-1·day-1) on cerebrovascular function using a randomized, single-blinded, placebo-controlled study design. We hypothesized that 7-day dietary nitrate supplementation would decrease variabilities in BP and CBF and improve CBF-CO2 slope and cerebral autoregulation (CA). We assessed beat-to-beat middle cerebral artery blood velocity (MCAv; index of CBF) and BP at rest and during CO2 breathing. Transfer function analysis was performed on beat-to-beat MCAv and BP to determine CA parameters (gain, phase, and coherence). Irrespective of treatment, high- and low-frequency BP-MCAv gain and MCAv-CO2 slope increased 7 days following TIA onset, while low-frequency BPV decreased (P < 0.05 vs. baseline). At follow-up, dietary nitrate elevated plasma nitrate concentration by ~547% (P < 0.001) and moderately lowered BPV (d = 0.6, P = 0.011), MCAv variability (d = 0.7, P = 0.018), and BP-MCAv coherence (d = 0.7, P = 0.008) in the very-low-frequency range (0.02-0.07 Hz), while MCAv-CO2 slope and arterial stiffness were unaffected (P > 0.05). Concurrent with standard treatment, dietary nitrate supplementation reduces BP and CBF fluctuation and improves cerebral autoregulation in TIA patients, without affecting cerebrovascular CO2 reactivity.NEW & NOTEWORTHY We found dietary nitrate supplementation reduced blood pressure and brain blood flow fluctuations and improved the relationship between blood pressure and brain blood flow in transient ischemic attack patients. Meanwhile, dietary nitrate had no effects on the brain blood vessels' response to CO2. We attribute the improved brain blood flow stability to the improved myogenic control of blood pressure with dietary nitrate. Our findings indicate that dietary nitrate could be an effective strategy for stabilizing blood pressure and brain blood flow following transient ischemic attack.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ataque Isquêmico Transitório Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ataque Isquêmico Transitório Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article